Friday, 26 March 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies

INBRAIN Neuroelectronics, a spin-off company of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, announces a €14.35M Series A investment, co-led by Asabys Partners and Alta Life Sciences, and joined by Vsquared Ventures (Germany), TruVenturo (Germany) and CDTI (Spanish Ministry of Science and Innovation). INBRAIN has the mission to develop intelligent neuroelectronic therapies based on graphene technology for application in patients with epilepsy, Parkinson’s and other brain related disorders.

Thursday, 25 March 2021

The origin of electrocaloric effect in PbZrO3, explained: antiferroelectric – ferroelectric phase switching

A research led by ICREA Prof. Gustau Catalán, group leader at the ICN2, and published in Physical Review proposes a response to the debate over the origin of the large negative electrocaloric effect observed in antiferroelectric PbZrO3. The understanding of the mechanism at the basis of this phenomenon is also relevant to its application to cooling systems for integrated circuits.

Wednesday, 24 March 2021

Dr Claudio Roscini awarded by the IAAM

The International Association of Advanced Materials conferred to ICN2 Senior Researcher Dr Roscini the Innovation Award given a talk at the prestigious lecture series of this institution.